Cigna Investments’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.02M | Sell |
3,248
-18
| -0.6% | -$5.67K | 0.13% | 123 |
|
|
2026
Q1 | $1.07M | Buy |
3,266
+19
| +0.6% | +$6.82K | 0.17% | 112 |
|
|
2025
Q4 | $1.14M | Sell |
3,247
-126
| -4% | -$45.9K | 0.16% | 108 |
|
|
2025
Q3 | $1.25M | Sell |
3,373
-13
| -0.4% | -$5.02K | 0.18% | 100 |
|
|
2025
Q2 | $1.34M | Sell |
3,386
-215
| -6% | -$80.4K | 0.23% | 86 |
|
|
2025
Q1 | $1.34M | Sell |
3,601
-74
| -2% | -$28.2K | 0.25% | 81 |
|
|
2024
Q4 | $1.32M | Sell |
3,675
-18
| -0.5% | -$6.67K | 0.23% | 81 |
|
|
2024
Q3 | $1.33M | Sell |
3,693
-65
| -2% | -$22.4K | 0.23% | 79 |
|
|
2024
Q2 | $1.28M | Buy |
3,758
+18
| +0.5% | +$6.1K | 0.24% | 83 |
|
|
2024
Q1 | $1.34M | Sell |
3,740
-27
| -0.7% | -$9.08K | 0.25% | 80 |
|
|
2023
Q4 | $1.13M | Sell |
3,767
-26
| -0.7% | -$7.3K | 0.23% | 92 |
|
|
2023
Q3 | $1.04M | Sell |
3,793
-417
| -10% | -$120K | 0.24% | 91 |
|
|
2023
Q2 | $1.28M | Sell |
4,210
-13
| -0.3% | -$3.75K | 0.24% | 83 |
|
|
2023
Q1 | $1.21M | Sell |
4,223
-64
| -1% | -$17K | 0.24% | 89 |
|
|
2022
Q4 | $1.05M | Sell |
4,287
-2
| -0% | -$454 | 0.22% | 102 |
|
|
2022
Q3 | $869K | Sell |
4,289
-182
| -4% | -$38.3K | 0.19% | 112 |
|
|
2022
Q2 | $890K | Sell |
4,471
-1,560
| -26% | -$366K | 0.18% | 122 |
|
|
2022
Q1 | $1.61M | Sell |
6,031
-1,649
| -21% | -$427K | 0.2% | 98 |
|
|
2021
Q4 | $2.05M | Sell |
7,680
-2,746
| -26% | -$721K | 0.16% | 105 |
|
|
2021
Q3 | $2.75M | Sell |
10,426
-32
| -0.3% | -$8.56K | 0.21% | 95 |
|
|
2021
Q2 | $2.72M | Sell |
10,458
-1,514
| -13% | -$387K | 0.19% | 99 |
|
|
2021
Q1 | $2.92M | Buy |
11,972
+246
| +2% | +$59K | 0.2% | 99 |
|
|
2020
Q4 | $2.87M | Buy |
11,726
+1,042
| +10% | +$236K | 0.22% | 88 |
|
|
2020
Q3 | $2.23M | Sell |
10,684
-2,323
| -18% | -$452K | 0.21% | 90 |
|
|
2020
Q2 | $2.34M | Buy |
13,007
+3,692
| +40% | +$681K | 0.22% | 90 |
|
|
2020
Q1 | $1.55M | Buy |
9,315
+550
| +6% | +$107K | 0.2% | 112 |
|
|
2019
Q4 | $1.85M | Sell |
8,765
-932
| -10% | -$193K | 0.2% | 110 |
|
|
2019
Q3 | $2.1M | Buy |
9,697
+677
| +8% | +$145K | 0.22% | 96 |
|
|
2019
Q2 | $1.89M | Sell |
9,020
-310
| -3% | -$59.2K | 0.21% | 105 |
|
|
2019
Q1 | $1.84M | Sell |
9,330
-167
| -2% | -$30.1K | 0.2% | 103 |
|
|
2018
Q4 | $1.49M | Sell |
9,497
-96
| -1% | -$16.1K | 0.13% | 112 |
|
|
2018
Q3 | $1.55M | Sell |
9,593
-958
| -9% | -$164K | 0.12% | 122 |
|
|
2018
Q2 | $1.78M | Sell |
10,551
-1,500
| -12% | -$252K | 0.13% | 119 |
|
|
2018
Q1 | $1.94M | Sell |
12,051
-30
| -0.2% | -$4.83K | 0.13% | 114 |
|
|
2017
Q4 | $1.87M | Sell |
12,081
-204
| -2% | -$31.1K | 0.12% | 128 |
|
|
2017
Q3 | $1.75M | Sell |
12,285
-90
| -0.7% | -$12.9K | 0.12% | 135 |
|
|
2017
Q2 | $1.72M | Sell |
12,375
-897
| -7% | -$123K | 0.12% | 130 |
|
|
2017
Q1 | $1.75M | Buy |
13,272
+1,558
| +13% | +$197K | 0.12% | 132 |
|
|
2016
Q4 | $1.4M | Buy |
+11,714
| New | +$1.35M | 0.15% | 159 |
|
Other funds holding SYK
GT
ATO
FAM
AAIS
RG
BTW
DC
JIC
Cigna Investments's SYK Position: Q2 2026 in Review
Cigna Investments reduced its Stryker (SYK) stake by 0.55% in Q2 2026, selling an estimated $5.67K and leaving 3,248 shares worth $1.02M. The position accounts for 0.13% of the portfolio, ranked #123.
Cigna Investments first reported a position in SYK in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.92M in Q1 2021. 832 funds tracked by Wall St. Rank hold SYK as of Q2 2026.
- Cigna Investments held 3,248 shares of Stryker worth $1.02M as of Q2 2026.
- Cigna Investments sold 18 Stryker shares in Q2 2026, an estimated $5.67K.
- Stryker made up 0.13% of Cigna Investments's portfolio in Q2 2026, its #123 holding.
- Cigna Investments first reported a position in Stryker in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Stryker position peaked at $2.92M in Q1 2021.
- 832 funds tracked by Wall St. Rank held Stryker as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.